Hyundai ADM Bio Inc. (KOSDAQ:187660)
South Korea
· Delayed Price · Currency is KRW 1,759.00
+49.00 (2.87%)
Last updated: Apr 18, 2025
Hyundai ADM Bio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Other Revenue | - | - | - | -0 | - | Upgrade
|
| Revenue | 9,745 | 13,790 | 14,883 | 13,978 | 13,120 | Upgrade
|
| Revenue Growth (YoY) | -29.33% | -7.34% | 6.47% | 6.54% | 28.55% | Upgrade
|
| Cost of Revenue | 9,687 | 10,605 | 10,560 | 6,772 | 5,720 | Upgrade
|
| Gross Profit | 57.97 | 3,185 | 4,323 | 7,205 | 7,400 | Upgrade
|
| Selling, General & Admin | 4,333 | 3,787 | 3,804 | 4,083 | 2,824 | Upgrade
|
| Research & Development | 10,725 | 569.66 | 587.01 | 627.73 | 727.77 | Upgrade
|
| Other Operating Expenses | 144.34 | 99.07 | 122.28 | 106.2 | 88.81 | Upgrade
|
| Operating Expenses | 16,052 | 5,096 | 5,078 | 5,115 | 3,870 | Upgrade
|
| Operating Income | -15,994 | -1,911 | -754.74 | 2,091 | 3,531 | Upgrade
|
| Interest Expense | -1,169 | -756.73 | -509.01 | -52.82 | -19.44 | Upgrade
|
| Interest & Investment Income | 513.31 | 950.69 | 667.14 | 177.97 | 127.17 | Upgrade
|
| Earnings From Equity Investments | 117.17 | 40.67 | 113.78 | 38.09 | 30.51 | Upgrade
|
| Currency Exchange Gain (Loss) | -9.03 | 11.41 | 0.43 | -0.01 | 6.31 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,734 | -252.14 | 629.75 | -84.08 | 902.98 | Upgrade
|
| EBT Excluding Unusual Items | -18,275 | -1,917 | 147.35 | 2,170 | 4,578 | Upgrade
|
| Gain (Loss) on Sale of Investments | 44.85 | 152.08 | -70.79 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -1.48 | -11.37 | - | 0.33 | 12.81 | Upgrade
|
| Pretax Income | -18,232 | -1,776 | 76.56 | 2,170 | 4,591 | Upgrade
|
| Income Tax Expense | -138.12 | 55.01 | 135.44 | 443.04 | 1,029 | Upgrade
|
| Earnings From Continuing Operations | -18,094 | -1,831 | -58.88 | 1,727 | 3,562 | Upgrade
|
| Earnings From Discontinued Operations | -2,167 | -1,532 | - | - | - | Upgrade
|
| Net Income to Company | -20,260 | -3,363 | -58.88 | 1,727 | 3,562 | Upgrade
|
| Minority Interest in Earnings | 164.52 | 392.98 | 325.39 | 195.58 | 213.17 | Upgrade
|
| Net Income | -20,096 | -2,970 | 266.5 | 1,923 | 3,775 | Upgrade
|
| Net Income to Common | -20,096 | -2,970 | 266.5 | 1,923 | 3,775 | Upgrade
|
| Net Income Growth | - | - | -86.14% | -49.07% | 393.92% | Upgrade
|
| Shares Outstanding (Basic) | 42 | 42 | 43 | 40 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 42 | 42 | 45 | 40 | 34 | Upgrade
|
| Shares Change (YoY) | - | -6.34% | 13.32% | 15.87% | 8.84% | Upgrade
|
| EPS (Basic) | -475.02 | -70.21 | 6.22 | 48.23 | 109.72 | Upgrade
|
| EPS (Diluted) | -475.02 | -70.21 | 6.22 | 48.00 | 109.72 | Upgrade
|
| EPS Growth | - | - | -87.05% | -56.25% | 353.81% | Upgrade
|
| Free Cash Flow | -14,346 | -15,513 | -512.83 | -384.44 | 5,247 | Upgrade
|
| Free Cash Flow Per Share | -339.11 | -366.68 | -11.35 | -9.64 | 152.53 | Upgrade
|
| Gross Margin | 0.60% | 23.09% | 29.05% | 51.55% | 56.41% | Upgrade
|
| Operating Margin | -164.13% | -13.86% | -5.07% | 14.96% | 26.91% | Upgrade
|
| Profit Margin | -206.22% | -21.54% | 1.79% | 13.76% | 28.77% | Upgrade
|
| Free Cash Flow Margin | -147.22% | -112.49% | -3.45% | -2.75% | 40.00% | Upgrade
|
| EBITDA | -14,405 | -352.41 | 330.96 | 2,792 | 4,064 | Upgrade
|
| EBITDA Margin | -147.82% | -2.56% | 2.22% | 19.98% | 30.98% | Upgrade
|
| D&A For EBITDA | 1,589 | 1,559 | 1,086 | 701.62 | 533.63 | Upgrade
|
| EBIT | -15,994 | -1,911 | -754.74 | 2,091 | 3,531 | Upgrade
|
| EBIT Margin | -164.13% | -13.86% | -5.07% | 14.96% | 26.91% | Upgrade
|
| Effective Tax Rate | - | - | 176.91% | 20.42% | 22.42% | Upgrade
|
| Advertising Expenses | 111.86 | 186.73 | 108.01 | 4.95 | 20.42 | Upgrade
|
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.